DK1153615T3 - Farmaceutisk formulering til intravenøs eller intramuskulær octreotid-indgivelse - Google Patents

Farmaceutisk formulering til intravenøs eller intramuskulær octreotid-indgivelse

Info

Publication number
DK1153615T3
DK1153615T3 DK00985268T DK00985268T DK1153615T3 DK 1153615 T3 DK1153615 T3 DK 1153615T3 DK 00985268 T DK00985268 T DK 00985268T DK 00985268 T DK00985268 T DK 00985268T DK 1153615 T3 DK1153615 T3 DK 1153615T3
Authority
DK
Denmark
Prior art keywords
intravenous
pharmaceutical formulation
intramuscular
octreotide
octreotide administration
Prior art date
Application number
DK00985268T
Other languages
Danish (da)
English (en)
Inventor
Obiols Berta Ponsati
Farres Gemma Jodas
Rodriguez Francisco J Clemente
Fernandez Sergi Pavon
Cabado Jordi Bacardit
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Application granted granted Critical
Publication of DK1153615T3 publication Critical patent/DK1153615T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00985268T 1999-12-17 2000-12-15 Farmaceutisk formulering til intravenøs eller intramuskulær octreotid-indgivelse DK1153615T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902769A ES2167189B1 (es) 1999-12-17 1999-12-17 Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
PCT/ES2000/000476 WO2001043776A1 (es) 1999-12-17 2000-12-15 Formulacion farmaceutica estable para la administracion intravenosa o intramuscular de octreotide

Publications (1)

Publication Number Publication Date
DK1153615T3 true DK1153615T3 (da) 2003-06-23

Family

ID=8310959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985268T DK1153615T3 (da) 1999-12-17 2000-12-15 Farmaceutisk formulering til intravenøs eller intramuskulær octreotid-indgivelse

Country Status (13)

Country Link
US (1) US6521599B2 (es)
EP (1) EP1153615B1 (es)
JP (1) JP4912551B2 (es)
AT (1) ATE233105T1 (es)
AU (1) AU763779B2 (es)
BR (1) BR0008249A (es)
CA (1) CA2362772C (es)
DE (1) DE60001489T2 (es)
DK (1) DK1153615T3 (es)
ES (2) ES2167189B1 (es)
MX (1) MXPA01008349A (es)
PT (1) PT1153615E (es)
WO (1) WO2001043776A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2508281C (en) * 2002-12-23 2011-08-09 Vical Incorporated Method for producing sterile polynucleotide based medicaments
PE20050285A1 (es) 2003-06-24 2005-06-09 Novartis Ag Composicion farmaceutica que comprende analogos ciclicos de somatostatina
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
CN103181893A (zh) * 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
CN102416001B (zh) * 2011-12-09 2013-06-05 重庆煜澍丰医药有限公司 一种注射用醋酸奥曲肽冻干粉针剂及其制备方法
CN111346214A (zh) * 2020-05-13 2020-06-30 吉林吉力生物技术研究有限公司 一种动物注射用醋酸奥曲肽冻干粉针剂及其制备方法和应用
CN114146054B (zh) * 2020-09-07 2022-12-02 深圳市健元医药科技有限公司 一种醋酸奥曲肽注射液的制备工艺
CN114288385B (zh) * 2021-12-27 2024-01-19 苏州天马医药集团天吉生物制药有限公司 一种醋酸奥曲肽制剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
TW249202B (es) * 1993-08-13 1995-06-11 Ciba Gerigy Corp
EP0896544B1 (en) * 1996-06-11 2003-02-26 Novartis AG Combination of a somatostatin analogue and a rapamycin

Also Published As

Publication number Publication date
DE60001489D1 (de) 2003-04-03
MXPA01008349A (es) 2004-03-19
AU763779B2 (en) 2003-07-31
PT1153615E (pt) 2003-06-30
DE60001489T2 (de) 2003-12-04
ES2167189A1 (es) 2002-05-01
ATE233105T1 (de) 2003-03-15
JP4912551B2 (ja) 2012-04-11
US6521599B2 (en) 2003-02-18
ES2193114T3 (es) 2003-11-01
EP1153615A1 (en) 2001-11-14
JP2003517024A (ja) 2003-05-20
CA2362772A1 (en) 2001-06-21
CA2362772C (en) 2010-03-16
WO2001043776A1 (es) 2001-06-21
ES2167189B1 (es) 2003-04-01
BR0008249A (pt) 2001-10-30
US20020128204A1 (en) 2002-09-12
EP1153615B1 (en) 2003-02-26
AU2173601A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
Amidon et al. Absorption of peptide and peptidomimetic drugs
KR920019371A (ko) 안정화된 인자 ⅷ 제제
ATE204467T1 (de) Orale darreichungsform
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
KR970061270A (ko) 히토성장호르몬을 함유하는 의약제제
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
DK1044015T3 (da) Formuleringer med amylinagonistpeptider og insulin
DK1153615T3 (da) Farmaceutisk formulering til intravenøs eller intramuskulær octreotid-indgivelse
WO2002042414A3 (en) Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
KR900016253A (ko) 아미드화 타우린 또는 글리신의 산부가염, 그의 제조방법과 용도
AU2003211474A1 (en) Stabilized albumin preparaions
RU2004133349A (ru) Жидкий препарат, содержащий производное кампототецина, и фармацевтическая композиция, получаемая путем лиофилизации препарата
JPS6416724A (en) Stable and injectable vinca dimer salt solution
DE69430416T2 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
Hussain et al. An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases
ATE149354T1 (de) Pharmazeutische zusammensetzung von stabilisiertem (leu 13>-motilin-hse
EP0296227A1 (en) Nasal delivery of amino acids
IT9048063A1 (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale
MX9708195A (es) Formulaciones para compuestos lipofilicos y uso de las mismas.